On September 28, we held a private presentation and lab tour in the Helen Diller Family Cancer Research Building at UCSF for a small group of our major donors and sponsors.
Dr. Pamela Munster, MD, director of UCSF’s early phase clinical trials, gave us a compelling presentation that reinforced how increasing the number and diversity of patients who participate in clinical trials is the key to promising cancer breakthroughs. This emphasized the value of Lazarex’s role in getting patients into clinical trials. We couldn’t help but give Dr. Munster resounding thumbs up, as we surely see eye-to-eye with her.
Dr. Munster then led us into an exciting discussion about cancer prevention and showed us a prototype device for women who are at high risk for having breast cancer due to a genetic mutation (like BRCA 2).The device can be implanted in the breast and deliver drugs locally to prevent cancer from growing. Additionally, UCSF scientist Scott Thomas treated us to a lab tour that offered insight into the development of this promising device and a smaller version being developed for prostate cancer.
Our guests were thoroughly engaged and came away with a greater appreciation for Lazarex and the program services that their funding supports.
Click here to see the entire photo album for the tour